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5. Figure 5: there are some inconsistencies in recording the death
of affected case III-10.
6. Phenotype D (on page 191): “In all 20 patients, either atrial
fibrillation (n 5 14) or AV block (n 5 7) was
documented. . . . ” Again the numbers do not add up
correctly. Should the text read ‘atrial fibrillation
and/or AV block’?
PASCAL MCKEOWN, MD
Regional Medical Cardiology Centre
Royal Victoria Hospital
Grosvenor Road
Belfast BT12 6BA
Northern Ireland
United Kingdom
e-mail: p.p.mckeown@qub.ac.uk
References
1. Gru¨nig E, Tasman JA, Ku¨cherer H, et al. Frequency and phenotypes of familial dilated
cardiomyopathy. J Am Coll Cardiol 1998;31:186–94.
2. Zachara E, Caforio ALP, Carboni GP, et al. Familial aggregation of idiopathic dilated
cardiomyopathy: clinical features and pedigree analysis in 14 families. Br Heart J
1993;69:129–135.
Reply
We thank Dr. McKeown for his supportive and critical comments
concerning our recently published manuscript. Our paper summarizes
a 5-year effort to elucidate the frequency and clinical phenotypes of
familial disease in 445 index patients with invasively documented
dilated cardiomyopathy (DCM). We could show that familial aggre-
gation of the disease is possibly present in 35% of all index patients.
These findings indicate the need for a careful history taking in patients
with DCM. As with any work that attempts to analyze the families of
445 index patients some important points cannot be addressed in a
depth due to limitations in time and manpower.
Thus, we agree that in 58 cases familial disease could not be
excluded definitely since we were not able to investigate the family
members for presence of dilated cardiomyopathy by clinical examina-
tion, ECG-recording, and cardiac ultrasound. Thus, indeed it may be
possible that the prevalence of familial disease may have been even
higher than reported. However, we have commented on this limitation
and thus had hoped that this limitation is apparent to the reader.
We also agree, that the definition of suspected DCM is rather
loose. However we felt: a) that the wording of “suspected” implies a
residual uncertainty, and b) that the diagnosis suspected DCM is still
a valid information, considering the difficulties of proper clinical
classification of the presence of absence of DCM.
Our intention was to emphasize that patients with familial DCM
may represent with different phenotypes, which are important for
diagnostic classification and for further risk stratification of the
patients and may be helpful for genetic analysis. The issue of potential
autosomal recessive disease was not explicitly addressed because an
autosomal recessive way of inheritance was not certainly observed in
our study and may indeed be very rare (2,3).
Table 1 summarizes the clinical definitions of phenotypes and their
possible genetic causes, whereas table 3 and 4 classify clinical findings
of the examined families. We agree that a more uniform presentation
may have facilitated the reading of the tables.
The major clinical difference between group A and B was that of an
elevation of creatine kinase activity in serum in group A patients. The
elevation of CK activity in blood was taken as evidence for the
involvement of skeletal muscle disease, which is a common finding in
patients with mutations of the dystrophin molecule. Indeed, we were
able to identify a dystrophin mutation in one of the two families. This
certainly is no proof that all cases of CK positive DCM may be caused
by dystrophin mutations. However, it is likely that dystrophin muta-
tions may also have been present in the second family.
We furthermore appreciate the detailed correction of typographi-
cal errors, although they do not pertain to any of the results or any of
the conclusions made in this study: Figure 1 n 5 108 instead of 110 and
Figure 5 III-10 n/ instead of n1. On page 191, “and/or” may indeed be
better than “or.” It is correct, that patient IV12 in Figure 2 should read
as cousin and not as nephew. Finally, it was not possible to give a
functional status in individuals diagnosed as DCM by autopsy, leading
to the erroneous conclusion of “missing data” in Table 3.
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